primary tumor

Type: Keyphrase
Name: primary tumor
First reported 4 hours ago - Updated 4 hours ago - 1 reports

Navidea Awarded $1.67M Fast Track NIH SBIR Grant for Evaluation of ...

Navidea Awarded $1.67M Fast Track NIH SBIR Grant for Evaluation of Lymphoseek(r) in Cervical CancerSep. 23, 2014 Business Editors/Health Editors/Health WritersDUBLIN, Ohio--(BUSINESS WIRE)--Sep. 23, 2014--Navidea Biopharmaceuticals, Inc. (NYSE MKT: ... [Published Finwin - 4 hours ago]
First reported 21 hours ago - Updated 5 hours ago - 7 reports

Gene expression patterns in pancreatic circulating tumor cells revealed -- ScienceDaily

Analysis of circulating tumor cells (CTCs) in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to ... [Published DailyMe.Com - 5 hours ago]
First reported Sep 20 2014 - Updated Sep 20 2014 - 1 reports

A new prognostic instrument to predict the probability of developing new cerebral metastases after ...

Addition of whole-brain irradiation (WBI) to radiosurgery for treatment of few cerebral metastases is controversial. This study aimed to create an instrument that estimates the probability of developing new cerebral metastases after radiosurgery to facilitate ... [Published 7thSpace - Sep 20 2014]
First reported Sep 18 2014 - Updated Sep 19 2014 - 2 reports

Navidea: FDA Grants Orphan Drug Status For Lymphoseek In Head, Neck Cancers

Navidea Biopharmaceuticals Inc (NAVB: Quote) said Thursday the U.S. Food and Drug Administration has granted orphan drug status to Lymphoseek (technetium Tc 99m tilmanocept) Injection for use in sentinel lymph node detection in patients with cancer of ... [Published RTTNews.com - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 1 reports

Toronto Mayor Rob Ford Diagnosed with Cancer

(TORONTO) -- Toronto Mayor Rob Ford has been diagnosed with cancer, his doctor said Wednesday.In a press conference at Mount Sinai Hospital in Toronto, Dr. Zane Cohen said that tests have confirmed a "fairly aggressive tumor" in the mayor's abdomen. Doctors ... [Published 1070wapi.com - Sep 17 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

You don’t have to stay strong, Rob Ford

Dear Rob Ford: I’m so sorry about the cancer. Even though I’m not usually the sort of person who and you don’t strike me as the type who reads them, when I heard about your recent diagnosis I thought I’d drop a line anyway, from a cancer veteran to a ... [Published Salon - Sep 18 2014]
Entities: Rob Ford, Cancer, Tumor
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Belgian Researchers Discover Way to Block Cancer Metastasis

Cancer remains one of the deadliest diseases, despite many new methods to combat it. Modern medicine has treatments to prevent the growth of primary tumor cells. But most cancer deaths are caused by metastasis, the stage when primary tumor cells change ... [Published VOA News - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels

by Paul Geeleher, Nancy Cox, R. Stephanie HuangWe recently described a methodology that reliably predicted chemotherapeutic response in multiple independent clinical trials. The method worked by building statistical models from gene expression and drug ... [Published Plosone.org - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 3 reports

Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates

Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy (SBRT) have a five-year survival rate of 40 percent, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th ... [Published Bio-Medicine - Sep 16 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Sequencing Analysis of Tumor DNA: Is It All in the Plasma?

By Britta Weigelt, PhD, and Jorge S. Reis-Filho, MD, PhD, FRCPathSeptember 15, 2014, Volume 5, Issue 15Massively parallel sequencing analyses have demonstrated that most of the common malignancies display relatively complex repertoires of somatic genetic ... [Published The ASCO Post - Sep 15 2014]
Entities: Tumor, Mutation, DNA, Cancer
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Detection and Quantitation of Circulating Tumor Cell Dynamics by Bioluminescence Imaging in an Orthotopic Mammary Carcinoma Model

by Laura Sarah Sasportas, Sharon Seiko Hori, Guillem Pratx, Sanjiv Sam GambhirCirculating tumor cells (CTCs) have been detected in the bloodstream of both early-stage and advanced cancer patients. However, very little is know about the dynamics of CTCs ... [Published Plosone.org - Sep 04 2014]
First reported Aug 28 2014 - Updated Aug 29 2014 - 4 reports

CTC clusters cause metastasis

Circulating tumor cell (CTC) clusters - clumps of from 2 to 50 tumor cells that break off a primary tumor and are carried through the bloodstream - appear to be much more likely to cause metastasis than are single CTCs, according to a study from inve ... [Published BioPortfolio - Aug 29 2014]

Quotes

...neck," said Michael T McHale, M D , Associate Professor, Fellowship Director, Division of Gynecologic Oncology, UC San Diego Moores Cancer Center. "There is currently a growing focus on sentinel lymph node biopsy (SLNB) procedures in gynecologic cancers. We are pleased to participate in this important study which will evaluate and compare the abilities of tilmanocept and an alternative detection agent to identify SLNs during cervical cancer surgery. If successful, this study could potentially advance the use of SLNB procedures in cervical cancer."
...of the ECM in this tumor seems to be of great importance," says Ting, who is an assistant professorprofessor of Medicine at Harvard Medical School. "Much effort has been focused on targeting the microenvironment to improve the efficacy of chemotherapy, and data indicating that environmental stromal cells can enhance a tumor's metastatic ability indicate that ECM proteins are important whether they are produced in stroma or within the tumor cells themselves. Now we need to investigate whether therapeutically targeting ECM can destroy both the tumor microenvironment and CTCs before they have a chance to metastasize."
"The V600E BRAF mutation is found in a number of tissue/tumor types including: nervous system, thyroid, skin, gastrointestinal tract, large intestine, biliary tract, ovary, eye, prostate, central nervous system, liver, small intestine, breast, pancreas, soft tissue, upper, aerodigestive tract, adrenal gland, autonomic ganglia, haematopoietic and lymphoid tissue, lung, esophagus, pituitary, and stomach. DNA or RNA extracted from samples of any of these types of tissues can be utilized in assays of the present invention."

More Content

All (133) | News (122) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Navidea Awarded $1.67M Fast Track NIH SBIR Gran... [Published Finwin - 4 hours ago]
Navidea Awarded $1.67M Fast Track NIH SBIR Gran... [Published Pettinga Financial Advisors - 5 hours ago]
Gene expression patterns in pancreatic circulat... [Published DailyMe.Com - 5 hours ago]
Gene Expression Patterns in Pancreatic CTCs Rev... [Published Technology Networks - 5 hours ago]
Massachusetts General study reveals gene expres... [Published Infrosoft - 18 hours ago]
Study reveals gene expression patterns in pancr... [Published BioPortfolio - 19 hours ago]
Study reveals gene expression patterns in pancr... [Published Medical Xpress - 20 hours ago]
Massachusetts General study reveals gene expres... [Published EurekAlert! - 20 hours ago]
Massachusetts General study reveals gene expres... [Published Bio-Medicine - 21 hours ago]
A new prognostic instrument to predict the prob... [Published 7thSpace - Sep 20 2014]
Tumor cells prep lymphatic cells to encourage b... [Published Chemotherapy Advisor - Sep 19 2014]
Orphan status for Navidea’s Lymphoseek in head ... [Published Pharma Letter - Sep 19 2014]
Navidea: FDA Grants Orphan Drug Status For Lymp... [Published RTTNews.com - Sep 18 2014]
Rosetta Genomics' (ROSG) CEO Kenneth Berlin on ... [Published Seeking Alpha - Sep 18 2014]
Exploring obesity-aggressive prostate cancer link [Published University at Buffalo Reporter - Sep 18 2014]
Navidea Receives Orphan Drug Designation from F... [Published CNBC - Sep 18 2014]
"Methods, Primers, Probes and Kits Useful for t... [Published 4 Traders - Sep 18 2014]
You don’t have to stay strong, Rob Ford [Published Salon - Sep 18 2014]
Belgian Researchers Discover Way to Block Cance... [Published VOA News - Sep 18 2014]
Toronto Mayor Rob Ford Diagnosed with Cancer [Published 1070wapi.com - Sep 17 2014]
pRRophetic: An R Package for Prediction of Clin... [Published Plosone.org - Sep 17 2014]
Single-Fraction RT for Bone Mets Should Be 'Sta... [Published General Medicine eJournal - Sep 17 2014]
ONLINE FIRST: Stage IV Lung Cancer: Long-Term S... [Published Oncology Times - Sep 16 2014]
Long-term results of RTOG 0236 confirm good pri... [Published Bio-Medicine - Sep 16 2014]
Longterm results of RTOG 0236 confirm good prim... [Published BioPortfolio - Sep 16 2014]
Long-term results of RTOG 0236 confirm good pri... [Published Medical Xpress - Sep 16 2014]
ASTRO: Imaging, radiation oncology increasingly... [Published Aunt Minnie - Sep 16 2014]
No Survival Benefits With Erlotinib and Whole-B... [Published The ASCO Post - Sep 15 2014]
Cancer Patients With Malignant Spinal Cord Comp... [Published Scottrade - Sep 15 2014]
TOMITA : Cancer patients with malignant spinal ... [Published 4 Traders - Sep 15 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Long-Term Results of RTOG 0236 Confirm Good Pri... [Published Marketwire - Breaking News Releases - Sep 15 2014]
SAN FRANCISCO, CA--(Marketwired - September 15, 2014) - Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy (SBRT) have a five-year survival rate of 40 percent, according to research presented today at the ...
Consortium of Academic Health Centers for Integ... [Published Science-Based Medicine - Jul 10 2014]
In May, the International Research Congress on Integrative Medicine and Health (IRCIMH) conference was held in Miami. In the words of its website, theconference was “convened by” the Consortium of Academic Health Centers for Integrative Medicine ...
More hype than science: Ketogenic diets for can... [Published ScienceBlogs : Combined Feed - Jun 24 2014]
If this looks a bit familiar to some of you, let’s just say that it’s grant crunch time again. This should be over after today. I hope. In the meantime, one of the difficult things about science-based medicine is determining what is and isn’t quackery. ...
Ketogenic diet does not “beat chemo for almost ... [Published Science-Based Medicine - Jun 23 2014]
One of the difficult things about science-based medicine is determining what is and isn’t quackery. While it is quite obvious that modalities such as homeopathy, acupuncture, reflexology, craniosacral therapy, Hulda Clark’s “zapper,” the Gerson therapy ...
Yeast studies suggest alternative cancer approach [Published MIT News feed - May 02 2014]
Yeast populations exposed to a sudden environmental shock can be driven to extinction, MIT researchers have shown. Could this principle also apply to human cancer cells? Possibly, argue researchers from MIT, Boston University, and Memorial Sloan-Kettering ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.